FDA Adverse Event Malfunction Summary report: N

UNICEL DXC 600I SYNCHRON ACCESS CLINICAL SYSTEMS

MDR report key: 1235760 · Received November 18, 2008

Report

Report Number
2050012-2008-00073
Event Type
Malfunction
Date Received
November 18, 2008
Date of Event
October 28, 2008
Report Date
November 18, 2008
Manufacturer
BECKMAN COULTER, INC.
Product Code
JJE
PMA / PMN Number
K060256
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
NO INFORMATION

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS SERUM. SERVICE WAS NOT DISPATCHED FOR THIS EVENT. TREATMENT WAS NOT IMPACTED IN THIS EVENT BECAUSE THE PHYSICIAN QUESTIONED THE RESULT. UPON RECUR, TREATMENT COULD BE INITIATED BASED ON THE FALSELY ELEVATED MG RESULT OBTAINED. TREATMENT INITIATED ON FALSELY ELEVATED MG RESULT COULD CONTRIBUTE TO SERIOUS INJURY. NO ADDITIONAL INFO REGARDING THIS VENT IS AVAILABLE. A CLEAR ROOT CAUSE FOR THIS EVENT HAS NOT BEEN DETERMINED TO DATE. A MALFUNCTION WILL BE ASSUMED FOR THE PURPOSE OF THIS REPORT.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) REGARDING HIGH MAGNESIUM (MG) RESULT GENERATED BY THE UNICEL DXC 600I SYNCHRON ACCESS CLINICAL SYSTEMS FOR ONE PT SAMPLE. A PT SAMPLE WITH INCORRECT RESULTS INITIALLY FLAGGED "OIR HI" WAS DILUTED 1:2 AND STILL WAS FLAGGED "OIR HI". (OIR- OUT OF INSTRUMENT RANGE). THE CUSTOMER THEN MADE A DILUTION 1:3 AND A RESULT OF 16.9MG/DL WAS OBTAINED. THE RESULT WAS REPORTED OUT OF THE LAB AND QUESTIONED BY THE PHYSICIAN BECAUSE IT DID NOT MATCH EARLIER RESULTS OF 9.0MG/DL AND 10.1MG/DL. PER CUSTOMER, THEY RERAN THE SAMPLE FOR MG ON TWO DIFFERENT INSTRUMENTS AND RESULTS WERE 8.6MG/DL AND 8.7MG/DL. IT IS UNK WHETHER THESE SAMPLES WERE RUN DILUTED. PT TREATMENT WAS NOT AFFECTED IN CONNECTION TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL DXC 600I SYNCHRON ACCESS CLINICAL SYSTEMS CLINICAL CHEMISTRY ANALYZER JJE BECKMAN COULTER, INC. DXC 600I NA

Patients

Seq Age Sex Outcome Treatment
1 NA